Follow-up: Prozac intrigue fizzles

Article

In February ( http://www.contemporarypediatrics.com/contpeds/article/articleDetail.jsp?id=147795), Updates reported an accusation made by the British Medical Journal (BMJ) that pharmaceutical manufacturer Eli Lilly & Co. had concealed documents linking the company's antidepressant Prozac (fluoxetine) to a heightened risk of suicide. Updates noted that Lilly denied the allegation but, regrettably, the February issue of Contemporary Pediatrics had already gone to press when BMJ editors retracted their statement and apologized to Lilly: "The BMJ accepts that Eli Lilly acted properly in relation to the disclosure of these documents ... and is happy to set the record straight and apologize."

Recent Videos
Geetika Kennady, MD, FAAP
Jillian Cotter, MD
Jesse Hinckley, MD, PhD
Validating digital stethoscope for pediatric breath sounds, with Jennifer Nestor, MD
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Sensory play for children with autism, with Joshua Feder, MD
Stephanie Chao, MD
Feasibility of ambulatory blood pressure monitoring in primary care | Carissa Baker-Smith, MD, MPH
Tina Tan, MD
Camille Walker CPNP-PC, MSN, CPNP Sacheen D. Harris MSN, CPNP-PC
© 2025 MJH Life Sciences

All rights reserved.